Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2941 to 2955 of 7690 results

  1. Executive team meetings

    NICE executive team meeting minutes and agenda

  2. History of NICE

    1999 Creation of NICE The National Institute for Clinical Excellence became a legal entity in April. Our aim was to create consistent guidelines

  3. Our charter

    An outline of the roles and responsibilities of the National Institute for Health and Care Excellence

  4. Our principles

    An outline of the key principles that are universal to all of NICE's guidance and standards.

  5. Corporate publications

    Links to our annual reports and business plan

  6. NICE Listens

    NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social...

  7. Quality standards: process guide (PMG43)

    This guide describes the process NICE uses to develop NICE quality standards

  8. Our role in the Innovative Licensing and Access Pathway (ILAP)

    The Innovative Licensing and Access Pathway (ILAP) aims to streamline patient access to safe, financially sustainable and innovative medicines.

  9. Overview: how we develop technology appraisal guidance

    1. Provisional appraisal topics chosen The NICE topic selection programme produces a list of provisional appraisal topics. 2. Stakeholders identified

  10. Developing NICE guidelines: the manual (PMG20)

    This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE

  11. Biosimilar technologies: NICE position statement

    There are 2 different points of the lifecycle of a NICE Technology Appraisal at which consideration of reference to or inclusion of a biosimilar is...

  12. Biosimilar technologies: NICE position statement - information for the public

    Biosimilar medicines – NICE's approach A biological medicine is any medicinal product made by or derived from a biological (natural) source, for...

  13. Participation in clinical trials and subsequent access to drugs appraised by NICE: a statement on the applicability of technology appraisal guidance

    Patients taking part in clinical trials may receive drugs which have been evaluated by NICE technology appraisal guidance. Queries have been raised...

  14. Technology appraisal position statements

    On this page, you'll find a list of all our position statements relating to our technology appraisal guidance. Biosimilar technologies: NICE position

  15. Technology appraisals - position statements

    On this page, you'll find all our position statements relating to technology appraisals. Biosimilar technologies: NICE position statement Biosimilar